Keywords
Severe acute respiratory syndrome
Child hospitalized
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To describe the clinical and epidemiological characteristics of children hospitalized with COVID-19 and assess the correlation between symptoms and length of hospital stay. Methods: A cross-sectional study included 48 patients ≤12 years old, hospitalized with COVID-19 between April 2020 and June 2021, at a pediatric hospital in northern Brazil. The majority were male children (54.2%), from Macapá, with a mean age of 24 months. The average duration of hospitalization was 5 days for those with mild symptoms (35.4%) and 10 days for those with Severe Acute Respiratory Syndrome (SARS) (64.6%). Results: Supplementary oxygen was required in 22.9% of patients, 2 children (4.2%) were admitted to the ICU, and only one case of Multisystem Inflammatory Syndrome (MIS) was confirmed. The main radiological finding was bilateral interstitial infiltrate. There were no deaths recorded during the study. There was an association between the presence of respiratory discomfort and hospital stay ≥7 days (p 0.017; Cramer's V 0.4). However, no association was found between other symptoms and length of hospital stay. Conclusion: The study indicated low RT-PCR testing rates during the virus dissemination phase.
References
ADIR Y, et al. Asthma and COVID-19: an update. European Respiratory Review, 2021; 30(162): 2101052.
ALKAN G, et al. Evaluation of hematological parameters and inflammatory markers in children with COVID-19. Ir. J. Med. Sci, 2022; 191(4): 1725-1733.
BAQUI P, et al. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Glob. Health, 2020; 8(8): 1018- 1026.
BELLINI T, et al. Characteristics of COVID‐19 patients up to 6 months of age admitted to a paediatric emergency department. Acta Paediatr, 2022; 11(2): 272-274.
BERNARDINO FBS, et al. Epidemiological profile of children and adolescents with COVID-19: a scoping review. Rev. Bras. Enferm, 2021; 74(1): 20200624.
BHUIYAN MU, et al. Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis. Vaccine, 2021; 39(4): 667-677.
BRASIL. Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde. Brasília, 2021. Disponível em: https ://covid.saude.gov.br/. Acessado em: 28 mai. 2021.
CARSETTI R, et al. The immune system of children: the key to understanding SARS-CoV-2 susceptibility? The Lancet Child & Adolescent Health, 2020; 4(6): 414-416.
DELAHOY MJ, et al. Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021. MMWR Morb Mortal Wkly Rep, 2021; 70(36): 1255-1260.
DONG Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics, 2020; 145(6): 20200702.
EJAZH, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J. Infect. Public Health, 2020; 13(12): 1833-1839.
GEBHARD C, et al. Impact of sex and gender on COVID-19 outcomes in Europe. Biology of Sex Differences, 2020; 11(1): 29.
GUO CX, et al. Epidemiological and clinical features of pediatric COVID-19. Bmc Medicine, 2020; 18(1): 250.
HUETE-PÉREZ JA, et al. Prevalence and risk factors for SARS-CoV-2 infection in children with and without symptoms seeking care in Managua, Nicaragua: results of a crosssectional survey. BMJ Open, 2021; 11(9): 51836.
INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA. Pesquisa Nacional por Amostra de Domicílios Contínua, 2021. Disponível em: https ://sidra.ibge.gov.br/tabela/6403. Acessado em: 04 fev. 2022.
KERMALI M, et al. The role of biomarkers in diagnosis of COVID-19 – A systematic review. Life Sci, 2020; 254: 117788.
KIM L, et al. Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1– July 25, 2020. MMWR Morbidity and Mortality Weekly Report, 2020; 69(32): 1081-1088.
MATTHAI, J. et al. Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children. Indian Pediatr, 2020; 57(6): 533-535.
MUNRO, A.P.S. et al. Covid-19 in children: current evidence and key questions. Curr. Opin. Infect. Dis, 2020; 33(6): 540-547.
MUSTAFA NM; SELIM LA. Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis. J. Clin. Virol, 2020; 128: 104395.
NACHEGAJB, et al. Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries. JAMA pediatrics, 2022; 176(3): 216436.
NINO G, et al. Chest X‐ray lung imaging features in pediatric COVID‐19 and comparison with viral lower respiratory infections in young children. Pediatr. Pulmonol, 2021; 56(12): 3892-3898.
NINO G, et al. Pediatric lung imaging features of COVID-19: A systematic review and metaanalysis. Pediatr. Pulmonol, 2021; 56(1): 252-263.
OLIVEIRA EA, et al. Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database. Lancet Child Adolesc. Health, 2021; 5(8): 559-568.
PASCARELLA G, et al. COVID-19 diagnosis and management: a comprehensive review. Journal of Internal Medicine, 2020; 288(2): 192-206.
PRATA-BARBOSA A, et al. Pediatric patients with COVID-19 admitted to intensive care units in Brazil: a prospective multicenter study. J. Peditr, 2020; 96(5): 582-592.
QI K, et al. Clinical, laboratory, and imaging features of pediatric COVID-19: A systematic review and meta-analysis. Medicine, 2021; 100(15): 25230.
RABHA AC, et al. Manifestações clínicas de crianças e adolescentes com COVID-19: relato dos primeiros 115 casos do Sabará Hospital Infantil. Rev. Paul. Pediatr, 2020; 39: 2020305.
RAZA HA, et al. Sex hormones, autoimmunity and gender disparity in COVID‑19. Rheumatology International, 2021; 41(8): 1375-1386.
SAFADI MAP. The intriguing features of COVID-19 in children and its impact on the pandemic. J. Pediatr, 2020; 96(3): 265-268.
SAMADIZADEH S, et al. COVID-19: Why does disease severity vary among individuals? Respiratory Medicine, 2021; 180: 106356.
SWANN OV, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ, 2020; 370: 3249.
TOSO BR, et al. Caracterização da COVID-19 em crianças hospitalizadas. Rev. Soc. Bras. Enferm. Ped, 2020; 20: 36-48.
WANGJ; YUAN X. Digestive system symptoms and function in children with COVID-19: A meta-analysis. Medicine (Baltimore), 2021; 100(11): 24897.
WATERFIELD T, et al. Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study. Arch. Dis. Child, 2021; 106(7): 680-686.
WIERSINGA WJ, et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA, 2020; 324(8): 782-793.
WORLD HEALTH ORGANIZATION (WHO). WHO Coronavirus (COVID-19) Dashboard. Disponível em: https://covid19.who.int/table. Acessado em: 28 mai. 2021.
XIA W, et al. Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults. Pediatri. Pulmonol, 2020; 55(5): 1169-1174.
ZHAOY, et al. The inflammatory markers of multisystem inflammatory syndrome in children (MIS‐C) and adolescents associated with COVID‐19: A meta‐analysis. J. Med. Virol, 2021; 93(7): 4358-4369.